2014 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
Simon Mallal mainly focuses on Immunology, Human leukocyte antigen, Virology, Immune system and Epitope. His Immunology study incorporates themes from Pharmacogenetics and Drug. His Human leukocyte antigen study combines topics from a wide range of disciplines, such as Major histocompatibility complex and Allele.
His Virology research integrates issues from Cellular immunity and Viral evolution. Simon Mallal has included themes like Breast cancer, Triple-negative breast cancer and Hepatitis C virus in his Immune system study. His Epitope research integrates issues from Cytotoxic T cell and CTL*.
Immunology, Virology, Human leukocyte antigen, Immune system and Genetics are his primary areas of study. His study ties his expertise on Drug together with the subject of Immunology. His work in Virology addresses issues such as Epitope, which are connected to fields such as Cytotoxic T cell.
His studies deal with areas such as Genotype, Allele, Haplotype and Viral load as well as Human leukocyte antigen. His research in Abacavir intersects with topics in Internal medicine, Hypersensitivity reaction, Genetic testing and Pharmacogenetics. In his study, Zidovudine is inextricably linked to Lipoatrophy, which falls within the broad field of Internal medicine.
His main research concerns Immunology, Human leukocyte antigen, T cell, Epitope and Immune system. Simon Mallal performs integrative study on Immunology and CD38 in his works. To a larger extent, he studies Genetics with the aim of understanding Human leukocyte antigen.
His T cell research includes elements of Cytotoxic T cell, Peripheral blood mononuclear cell and CD8. His research investigates the connection with Epitope and areas like Virology which intersect with concerns in HIV integration. His work in Antigen covers topics such as Parkinson's disease which are related to areas like Major histocompatibility complex.
His primary scientific interests are in Immunology, Epitope, T cell, Human leukocyte antigen and Virology. The various areas that Simon Mallal examines in his Immunology study include Raltegravir and DNA sequencing. His study looks at the relationship between Epitope and topics such as Cytotoxic T cell, which overlap with T-cell receptor and Adipocyte.
His T cell research incorporates elements of Levodopa, Internal medicine and CD8. His study on Human leukocyte antigen is covered under Genetics. His Virology study combines topics from a wide range of disciplines, such as Virus Integration and Epitope mapping.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Simon Mallal;Elizabeth Phillips;Giampiero Carosi;Jean-Michel Molina.
The New England Journal of Medicine (2008)
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S. Mallal;S. Mallal;D. Nolan;C. Witt;C. Witt;G. Masel;G. Masel.
The Lancet (2002)
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo.
Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level
Corey B. Moore;Mina John;Ian R. James;Frank T. Christiansen;Frank T. Christiansen.
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
Photini Kiepiela;Alasdair J Leslie;Isobella Honeyborne;Danni Ramduth.
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.
Simon A Mallal;Mina John;Corey B. Moore;Ian R. James.
The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases
Patricia Price;C. Witt;R. Allcock;D. Sayer.
Immunological Reviews (1999)
Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy
M.A. French;N. Lenzo;M. John;S.A. Mallal.
Hiv Medicine (2000)
Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant
Annalise M. Martin;David Nolan;Silvana Gaudieri;Silvana Gaudieri;Coral Ann Almeida.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Adaptation of HIV-1 to human leukocyte antigen class I
Y. Kawashima;K. Pfafferott;J. Frater;P. Matthews.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: